DSW (DSW) was downgraded to hold at Jefferies. $25 price target. The company has limited earnings upside potential, Jefferies said.
Dexcom (DXCM) was downgraded to equal-weight from overweight at Morgan Stanley. $66 price target. Libre risk is not yet factored into the stock, Morgan Stanley said.
Medtronic (MDT) was downgraded to equal-weight from overweight at Morgan Stanley. $77 price target. The company is facing growth challenges, Morgan Stanley said.
Methanex (MEOH) was downgraded to market perform from outperform at Raymond James. $48 price target. Methanol prices will likely fade soon, Raymond James said.
Nokia (NOK) was downgraded to neutral from outperform at Oppenheimer. The company is seeing muted spending trends, Oppenheimer said.
Paccar (PCAR) was downgraded to neutral from outperform at Baird. $62 price target. The valuation is less attractive, as the stock outperformed the broader market by 25% last year, Baird said.
Verizon (VZ) was upgraded to buy from neutral at Citigroup. $60 price target. The company is expanding its addressable market, Citi said.
Xilinx (XLNX) was downgraded to reduce from neutral at Nomura. $45 price target. The valuation is less attractive, as the company is valued at 26x expected earnings, Nomura said.
Xerox (XRX) was upgraded to outperform from neutral at Credit Suisse. $8 price target. Cost-savings should drive margin expansion, following the business spin, Credit Suisse said.